Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Working Capital to Net Assets Ratio
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Working Capital to Net Assets ratio of 11.8% as of June 2025. Working capital of $41.66 Million (current assets of $177.57 Million minus current liabilities of $135.91 Million) is measured against net assets of $352.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Zhengye Biotechnology Holding Limited Or to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Zhengye Biotechnology Holding Limited Ordinary Shares Working Capital to Net Assets (2021–2025)
This chart shows how Zhengye Biotechnology Holding Limited Ordinary Shares's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the ratio stands at 11.8%, reflecting working capital of $41.66 Million against net assets of $352.54 Million USD. For the complete balance sheet picture, see ZYBT total asset value.
Annual Working Capital to Net Assets for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Zhengye Biotechnology Holding Limited Or liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.8% | $41.66 Million | $352.54 Million | $177.57 Million | $135.91 Million | ▲ +0.0 pp |
| 2024 | 11.8% | $41.66 Million | $352.54 Million | $177.57 Million | $135.91 Million | ▼ -4.5 pp |
| 2023 | 16.3% | $55.36 Million | $339.27 Million | $205.59 Million | $150.23 Million | ▼ -1.1 pp |
| 2022 | 17.4% | $62.08 Million | $356.87 Million | $214.31 Million | $152.23 Million | ▲ +5.1 pp |
| 2021 | 12.3% | $39.32 Million | $318.84 Million | $164.94 Million | $125.63 Million | — |